UNCERTAINTY Immunology of Covid-19 Dr Gareth Kantor Immunology / - - PowerPoint PPT Presentation

uncertainty
SMART_READER_LITE
LIVE PREVIEW

UNCERTAINTY Immunology of Covid-19 Dr Gareth Kantor Immunology / - - PowerPoint PPT Presentation

Foresight Dialogues Web Series 2020 UNCERTAINTY Immunology of Covid-19 Dr Gareth Kantor Immunology / immunity Sept 1, 2020 Issues & implications Immunology 101 for non-immunologists (Iwasaki: Yale) 46,586 publications August 30


slide-1
SLIDE 1
slide-2
SLIDE 2

Immunology / immunity Issues & implications UNCERTAINTY

Foresight Dialogues Web Series 2020 Immunology of Covid-19 Dr Gareth Kantor Sept 1, 2020

slide-3
SLIDE 3

Immunology 101 for non-immunologists (Iwasaki: Yale)

slide-4
SLIDE 4

46,586 publications

https://www.ncbi.nlm.nih.gov/research/coronavirus/

August 30

slide-5
SLIDE 5

Pattern recognition Fast (hrs – days) Non-specific Signal neighbouring cells to put up barriers Signal infected cells die Recruit white blood cells to stimulate long lasting immunity

  • 1. INNATE IMMUNITY

(+ INFLAMMATION)

Cytokines

Image: Iwasaki (Yale)

slide-6
SLIDE 6
  • 2. ADAPTIVE IMMUNITY

Slow (96 hrs) Specific Long-term

Image: Iwasaki (Yale)

slide-7
SLIDE 7

NEUTRALIZING ANTIBODIES NON-NEUTRALIZING ANTIBODIES T-CELLS

Images: Iwasaki (Yale)

slide-8
SLIDE 8

Almost all produce antibodies Amount correlates with severity ↓ over time TIME COURSE

Nat Rev Immunol (2020). https://doi.org/10.1038/s41577-020-00436-4

2 weeks

slide-9
SLIDE 9

sterilizing immunity functional immunity waning immunity lost immunity a matter of degrees, not absolutes

https://www.statnews.com/2020/08/25/four-scenarios-on-how-we-might-develop-immunity-to-covid-19/

response protection IMMUNITY

slide-10
SLIDE 10

https://www.medrxiv.org/content/10.1101/2020.04.10.20060905v2 ↑ cytokines ↑ activation ↑ functional response

BCG VACCINATION trained immunity Epigenetic and metabolic programming of innate cells

slide-11
SLIDE 11
  • 3. MEMORY

B cells T cells etc

Image: Iwasaki (Yale) Image: Iwasaki (Yale)

slide-12
SLIDE 12
  • a. Delayed innate response; less

interferon; “exhausted” T-cells

  • b. Both innate and adaptive

systems compromised

  • c. More virus; migration to other

tissue

  • d. Prolonged immune system

activation

CYTOKINE STORM Treatment implications

Image: Iwasaki (Yale)

slide-13
SLIDE 13

Months later (140 days) Not sick Different strains New infection vs persistence Immunity is not absolute “sterilizing” REINFECTION

slide-14
SLIDE 14

"Female patients mounted significantly more robust T cell activation than male patients during SARS-CoV-2 infection, which was sustained in old age" Implications for vaccine dosing GENDER AGE

slide-15
SLIDE 15

Less susceptible Less sick MIS-C More vigorous immune response May carry/transmit - but less KIDS

slide-16
SLIDE 16

IMAGE: NY TIMES

20 – 50 % of people who were never exposed to SARS-CoV-2 have significant numbers of T-cells that can recognize it.

Functional relevance?

+/-

PRE-EXISTING IMMUNITY

Common human coronaviruses (229E, NL63, OC43, HKU1) cause mild/moderate upper-respiratory tract illnesses like the common cold. Nat Rev Immunol (2020). https://doi.org/10.1038/s41577-020-0389-z.

slide-17
SLIDE 17

Image: conversation.com https://www.mdpi.com/2076-0817/9/3/240/htm

Gene variants associated with respiratory failure

1. Region of genome that determines ABO blood type. 2. Near genes that encodes a protein that interacts with the ACE receptor the virus uses to enter human cells 3. Near genes that encode immune response

GENETICS

slide-18
SLIDE 18
  • Professional use only
  • Epidemiologic study (PREVALENCE)
  • Not diagnostic
  • Not predictive of immunity

ANTIBODY TESTING

“Diagnose COVID-19 retrospectively in patients who have recovered from a COVID- 19 compatible illness”. Diagnose COVID-19 in patients in who are “admitted with suspected SARS-CoV2 infection but who test negative [RT-PCR]”. Children with multi-inflammatory syndrome

Aug 26 launch by private labs + Single point of care test

slide-19
SLIDE 19

https://www.bmj.com/content/369/bmj.m1808/infographic

PREVALENCE

slide-20
SLIDE 20

https://www.bmj.com/content/369/bmj.m1808/infographic

The crucial thing is not the test itself but what you do in response. Quarantine (stop transmission) Diagnose and treat Admit to a COVID ward “Immunity passport” ☓ PREVALENCE (pre-test probability)

slide-21
SLIDE 21

+ distancing + VACCINE HERD IMMUNITY

slide-22
SLIDE 22

LONG COVID 10-20% Residual damage Ongoing inflammation?

slide-23
SLIDE 23

Complicated, amazing system Three phases – innate, adaptive, memory Balance and timing; in severe COVID-19 is lost Immunity is degrees not absolutes Uncertainty for medicine and policy Answers emerging SUMMARY

https://geekymedics.com/immune-response/